Wolverine Asset Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Wolverine Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $63,143 - $74,905	-110 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $78,484 - $92,717	-166 Reduced 60.14%	110 $61,000
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $90,239 - $110,736	202 Added 272.97%	276 $130,000
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $60,744 - $77,213	-127 Reduced 63.18%	74 $35,000
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $106,771 - $129,009	196 Added 3920.0%	201 $112,000
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $2,466 - $3,219	5 New	5 $3,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.